Comparing Disease‐Free Survival (DFS) and Overall Survival (OS) Rates in Breast Cancer Patients: Axillary Lymph Node Dissection (ALND) Versus Sentinel Lymph Node Biopsy (SLNB)
Open Access
- 1 January 2026
- journal article
- Published by Wiley in International Journal of Breast Cancer
- Vol. 2026 (1) , 5039446
Abstract
Background: Examining the survival rate in breast cancer patients serves as a metric for assessing and advancing various treatment modalities. In light of the significant incidence of breast cancer in Iran, this study is aimed at examining and comparing the disease‐free survival (DFS) and overall survival (OS) rates among breast cancer patients who underwent axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SLNB). Patients and Methods: This retrospective cohort research included 1071 patients at Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, from 1991 to 2021. The recurrence and survival rates of patients undergoing ALND and SLNB in both groups were examined and evaluated. The data were analyzed using SPSS statistical software using descriptive statistical techniques (percentage, frequency, mean, and standard deviation), Kaplan–Meier analysis, and Cox regression tests. A significance threshold of 0.05 is used. Results: The average OS among all patients was 18.08 ± 0.51. The average OS in the ALND group was 18.1 ± 0.53; in the SLNB group, it was 12.8 ± 0.39, which was insignificant ( p < 0.05). The average DFS among all patients was 17.13 ± 0.51. The average DFS in the ALND group was 16.95 ± 0.54; in the SLNB group, it was 11.96 ± 0.3; the difference was insignificant ( p = 0.11). Conclusion: OS and DFS in the ALND group were higher than in the SLNB group, but they were not statistically significant.Keywords
This publication has 39 references indexed in Scilit:
- A Randomized Clinical Trial on Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast CancerAnnals of Surgery, 2008
- Biologic and Clinical Characteristics of Breast Cancer With Single Hormone Receptor–Positive PhenotypeJournal of Clinical Oncology, 2007
- Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011Journal of Clinical Oncology, 2007
- Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled studyThe Lancet Oncology, 2006
- Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of International Breast Cancer Study Group Trial 10-93Journal of Clinical Oncology, 2006
- Treatment Trends in Early-Stage Invasive Lobular CarcinomaAnnals of Surgery, 2005
- Prognostic Factors After Conservative Surgery and Radiation Therapy for Early Stage Breast CancerAmerican Journal of Clinical Oncology, 1998
- Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla.1988
- THE ACCURACY OF CLINICAL NODAL STAGING AND OF LIMITED AXILLARY DISSECTION AS A DETERMINANT OF HISTOLOGIC NODAL STATUS IN CARCINOMA OF THE BREAST1981
- THE RESULTS OF RADICAL OPERATIONS FOR THE CURE OF CARCINOMA OF THE BREAST.*Annals of Surgery, 1907